Lille-based digital health company Axomove has secured €4 million in a Series A funding round to accelerate the commercial rollout of its platform and expand its footprint in the digital healthcare market. Notably, the round highlights rising investor confidence in preventive healthcare, rehabilitation technology, and digital therapeutics across Europe.
The funding round was co-led by Bpifrance through its Digital Prevention Fund and Go Capital, while Inco Ventures and existing investor Faraday Venture Partners also participated. Through this strategic backing, Axomove aims to strengthen its position in the fast-growing digital health and medtech ecosystem.
“The confidence of leading institutional investors validates the relevance of our strategy and reinforces our ambition to become a standard of care in prevention and rehabilitation,” said Boris Lévêque, co-founder and CEO of Axomove.
Founded in 2019, Axomove delivers a personalised care pathway that integrates digital health tools with continuous follow-up by healthcare professionals after a hospital episode. As a result, the company addresses the growing demand for hybrid healthcare models that combine remote monitoring, patient engagement, and clinical support.
Moreover, the company reports measurable clinical outcomes, as its solution doubles patients’ functional capacity and increases treatment adherence fivefold. In addition, Axomove generates significant economic and social benefits, including a 50% reduction in absenteeism and a threefold decrease in healthcare expenses, thereby making it highly relevant for employers, insurers, and healthcare systems.
“Since our entry in 2022, Axomove has demonstrated very strong execution capabilities, validating its proposition both clinically and commercially. The combination of a digital solution and healthcare support is effectively addressing a structural issue, such as musculoskeletal disorders, with tangible impact on patients and companies. The project’s evolution, together with the quality of the team and their ambition, reinforces our conviction to continue supporting them in this new phase of growth,” said Gonzalo Tradacete, CEO and founder of Faraday Venture Partners.
Previously, in 2022, the company raised €1.6 million with support from Faraday Venture Partners, alongside home care group Santélys and Groupe JLO, which helped lay the foundation for its current growth trajectory.
With the newly raised capital, Axomove will actively expand its commercial presence across corporate, insurance, and healthcare provider segments. At the same time, the company will extend reimbursement coverage to additional musculoskeletal conditions and metabolic diseases, particularly obesity. Furthermore, it will enhance its technology platform by integrating advanced motion capture capabilities and gamification features to improve user engagement and patient outcomes.
Currently, Axomove serves over 150 clients, including hospitals, corporations, and insurers such as Air France, Thales, Allianz, Alliance Klesia-Generali, CHU de Lille, and Ramsay Santé, collectively reaching 75,000 users. Importantly, the French Social Security already reimburses its solution for patients suffering from lower back pain, which further validates its clinical effectiveness and accessibility.
Axomove currently employs a team of 30 professionals and plans to double its workforce over the next three years, signaling strong growth ambitions in the digital health and rehabilitation technology space.
Axomove’s €4 million Series A funding marks a pivotal step in scaling its digital healthcare solutions and advancing preventive care models. As demand for digital therapeutics, remote patient monitoring, and rehabilitation platforms continues to grow, Axomove is well-positioned to emerge as a key player in transforming patient outcomes, reducing healthcare costs, and driving innovation in the global healthtech sector.
